Side-specific Factors for Intraoperative Hemodynamic Instability in Pheochromocytoma
1 other identifier
observational
171
0 countries
N/A
Brief Summary
The performance of adrenalectomy for pheochromocytoma (PHEO) presents significant challenges due to the presence of elevated intraoperative hemodynamic instability (HI) and conversion risk. The objective of this study was to conduct a comparative analysis of the occurrence and determinants of perioperative hypotension (HI) and conversion in left-sided (LLA) and right-sided (RLA) transabdominal laparoscopic adrenalectomy (TLA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 26, 2023
CompletedFirst Posted
Study publicly available on registry
October 3, 2023
CompletedJune 11, 2024
June 1, 2024
7 years
September 26, 2023
June 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
hemodynamic instability
incidence of hemodynamic instability
intraoperative and immediate postoperative
Secondary Outcomes (1)
conversion rate
intraoperative
Study Arms (2)
laparoscopic right adrenalectomy
laparoscopic right adrenalectomy for pheochromocytoma
laparoscopic left adrenalectomy
laparoscopic left adrenalectomy for pheochromocytoma
Interventions
laparoscopic adrenalectomy for pheochromocytoma
Eligibility Criteria
A total of 271 patients (n = 271) were involved in the study and subsequently separated into two groups: LRA (n = 122) and LLA (n = 149).
You may qualify if:
- \- patients \>18 years, both sex with unilateral PHEO of any size who underwent TLA
You may not qualify if:
- Patients who have undergone initial open adrenalectomy, various surgical procedures during total laparoscopic adrenalectomy (TLA), complete adrenalectomy,
- bilateral PHEOS bleeding diathesis, skeletal deformity, pregnancy, previous homolateral abdominal surgery, missing data, questionable preoperative diagnosis, inherited PHEO, or recurrent PHEO.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professour of general and laparoscopic surgery
Study Record Dates
First Submitted
September 26, 2023
First Posted
October 3, 2023
Study Start
September 1, 2016
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
June 11, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share